Women with Type 2 diabetes are less likely than men prescribed for statins to prevent heart attacks and strokes.
The condition that occurs when the body does not produce insulin properly will increase the risk of cardiovascular diseases in both sexes.
However, a study published in the journal Circulation suggests there may be a "prescription bias" in treatment.
The research, funded by the charity Diabetes UK, also found that men and women with the condition now experience a similar increase in their risk of cardiovascular disease.
Previously, a greater proportionate increase was seen in women, the authors
Researchers from the University of Manchester have analyzed the data of 80,000 people newly diagnosed with type 2 diabetes in England between 2006 and 201
Among this group, 11.6% of women and 12.8% of men went on to develop cardiovascular
Meanwhile, women with type 2 diabetes were 26% less likely to be prescribed ACE inhibitors and 16% less likely to have
They also found that women who already had some symptoms of cardiovascular disease were 37% less likely to receive ACE inhibitors and 41% less likely to receive statins than men.  Dr. Elizabeth Robertson, director of research at Diabetes UK, said: "These new results suggest that the outlook for women with Type 2 diabetes is better than previously thought, thanks to improved care."
"However, we need to make sure that everyone with Type 2 diabetes gets the best treatments and care to reduce their risk of life-threatening cardiovascular complications such as heart attack or stroke as much as possible. "
The researchers believe that gender bias in prescriptions may be due to
Dr. Martin Rutter, senior research scientist at the University of Manchester, said: "Further research is now needed to understand the reasons for
"Research in primary care is especially needed, as this is where most people with type 2 diabetes s are treated. "
– Press Association